ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 133 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $622,000 | -82.0% | 52,800 | -79.1% | 0.02% | -81.7% |
| Q1 2019 | $3,456,000 | -9.3% | 253,200 | -31.9% | 0.12% | -18.4% |
| Q4 2018 | $3,810,000 | -35.3% | 371,700 | +5.1% | 0.15% | -43.9% |
| Q3 2018 | $5,889,000 | +383.9% | 353,700 | +359.4% | 0.26% | +297.0% |
| Q2 2018 | $1,217,000 | -47.1% | 77,000 | -57.5% | 0.07% | -61.8% |
| Q1 2018 | $2,301,000 | +272.9% | 181,234 | +236.5% | 0.17% | +170.3% |
| Q2 2017 | $617,000 | -60.4% | 53,865 | -28.2% | 0.06% | -59.0% |
| Q1 2017 | $1,560,000 | +411.5% | 75,000 | +704.6% | 0.16% | +200.0% |
| Q3 2016 | $305,000 | +32.6% | 9,321 | +1.2% | 0.05% | +2.0% |
| Q2 2016 | $230,000 | – | 9,215 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,628,328 | $33,869,000 | 14.72% |
| Foresite Capital Management II, LLC | 995,396 | $20,704,000 | 10.39% |
| Cormorant Asset Management, LP | 1,581,604 | $32,897,000 | 4.43% |
| DAFNA Capital Management LLC | 221,013 | $4,597,000 | 4.04% |
| New Leaf Venture Partners, L.L.C. | 228,428 | $4,751,000 | 3.40% |
| Partner Investment Management, L.P. | 63,571 | $1,322,000 | 1.75% |
| Iguana Healthcare Management, LLC | 140,000 | $2,912,000 | 1.74% |
| PFM Health Sciences, LP | 2,913,951 | $60,610,000 | 1.71% |
| Redmile Group, LLC | 920,550 | $19,147,000 | 1.65% |
| SECTORAL ASSET MANAGEMENT INC | 669,351 | $13,923,000 | 1.54% |